However, the time-dependent AUC of 2 years and 3 years in patients with IDH-wildtype glioma (0.6880, 0.8218 in CGGA ; 0.6997, 0.7747 in TCGA; Figure S2A and B) were not as well as patients with IDH-mutant glioma. The gene discussed is IDH1; the disease is central nervous system cancer.